GEA Group Greater China

GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and high-tech plants as well as advanced process technology, components and comprehensive services for tomorrow’s food and beverage assortment. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.

Fii

作为全球领先的高端智能制造及工业互联网服务商,工业富联(全称:富士康工业互联网股份有限公司,股票代码:601138)坚持“数据驱动、绿色发展”的战略方向,业务已实现对数字经济产业五大类——云及边缘计算、工业互联网、智能家居、5G及网络通讯设备、智能手机及智能穿戴设备的全覆盖,在产品、技术以及全球市占率方面极具优势。
自2018年上市以来,公司依托于数字经济新基建的发展机遇,推动“高端智能制造+工业互联网”的四大核心业务高质量发展,实现产品技术的持续创新,公司业绩稳步增长。受益于AI算力需求强劲增长带动公司盈利能力提升,2024年全年营业收入6091.35亿元,同比增长27.88%;归母净利润232.16亿元,同比增长10.34%,营收利润均创新高。

Boehringer Ingelheim China

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need.

Merit Medical (Beijing) Co., Ltd

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit employs approximately 7,100 people worldwide with facilities.

Takeda China

About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology.

QuidelOrtho

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $2.8 billion in 2024 and has approximately 7,000 employees.